Muthanna Sultan, Hasan Alghetaa, Amirah Mohammed, Osama A. Abdulla, Paul J. Wisniewski, Narendra Singh, . . . Mitzi Nagarkatti. (2021). The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMuthanna Sultan, Hasan Alghetaa, Amirah Mohammed, Osama A. Abdulla, Paul J. Wisniewski, Narendra Singh, Prakash Nagarkatti, and Mitzi Nagarkatti. The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating MiRNA That Target Inflammatory Pathways. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationMuthanna Sultan, et al. The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating MiRNA That Target Inflammatory Pathways. Frontiers Media S.A., 2021.